ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nikolaizik, W.
Right arrow Articles by Warner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolaizik, W.
Right arrow Articles by Warner, J.
Eur Respir J 1997; 10: 2596-2601
Copyright © ERS Journals Ltd 1997

Original Articles

One year follow-up study of endocrine and lung function of asthmatic children on inhaled budesonide

WH Nikolaizik, MA Preece, and JO Warner

Inhaled corticosteroids have become a mainstay in the management of chronic asthma. Their use had been considered safe, although some degree of adrenal suppression has been demonstrated after 2 and 4 weeks of treatment with either 400 microg x day(-1) of beclomethasone dipropionate or budesonide. To weigh the benefits and risks of long-term treatment, 12 children with moderately severe asthma were assessed in a follow-up study on budesonide 200 microg b.i.d. After 1 yr, the nocturnal cortisol production was significantly reduced by 19%, but no greater compared to 2 and 4 weeks of treatment. Growth and growth hormone levels were normal. Lung function tests were significantly better, not only versus baseline values but also versus 2 and 4 weeks of treatment. We conclude that systemic effects of inhaled corticosteroids in conventionally low doses do not accumulate with length of treatment, whilst lung function parameters will continue to improve. Therefore, inhaled corticosteroids once started in asthmatic children not controlled on other medications should be continued, but their use should be carefully considered and the minimal dose required to control the asthma employed.


This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
K A Dunlop, D J Carson, H J Steen, V McGovern, J McNaboe, and M D Shields
Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression
Arch. Dis. Child., August 1, 2004; 89(8): 713 - 716.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. B. Bacharier, H. H. Raissy, L. Wilson, B. McWilliams, R. C. Strunk, and H. W. Kelly
Long-Term Effect of Budesonide on Hypothalamic-Pituitary-Adrenal Axis Function in Children With Mild to Moderate Asthma
Pediatrics, June 1, 2004; 113(6): 1693 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. P. Nielsen, R. Dahl, E. Derom, and R. Pauwels

Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2115 - 2115.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. DEROM, J. VAN SCHOOR, W. VERHAEGHE, W. VINCKEN, and R. PAUWELS
Systemic Effects of Inhaled Fluticasone Propionate and Budesonide in Adult Patients with Asthma
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 157 - 161.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.